Featured Research

from universities, journals, and other organizations

Shades of grey and prostate cancer

Date:
July 23, 2012
Source:
Inderscience
Summary:
Scientists in France have developed a computer program that can analyse in detail different shades of grey in medical images. They explain how the program based on the Grey Level Difference Method can improve accuracy in the diagnosis of prostate cancer.

Scientists in France have developed a computer program that can analyse in detail different shades of grey in medical images. Writing in a recent issue of the International Journal of Signal and Imaging Systems Engineering, they explain how the program based on the Grey Level Difference Method can improve accuracy in the diagnosis of prostate cancer.

Salah Bourennane and colleagues at the Fresnel Institute in Marseille, France, explain how multi-band signal analysis has become a focus in remote sensing, colour analysis, and in industrial inspection. More recently, it has been used in medical imaging. The approach allows roughness, smoothness and other characteristics of a three-dimensional structure to be ascertained with greater precision than other methods. It works well for analysing urban landscapes and surface damage to engineering components, for instance.

The team has now extended the approach to the analysis of images obtained during medical imaging, which are commonly monochromatic. In the present case, the computer program was tested on some 624 images are from prostatic tissue needle biopsy where different forms of the disease were present. By using the extended GLDM method of multi-band analysis, the researchers were able to extract far more information from such a grey-scale image than is commonly possible simply by visual inspection or conventional image processing techniques.

The team analysed at an approximate average level of 50 shades of grey (either 32 or 64 grey levels). With the conventional GLDM method diagnostic accuracy was about 92%, with their extended approach, they boosted that to almost 96% on retrospective analysis of the 624-image database. This bodes well for the improvement of prostate cancer diagnosis using biopsy imaging.

"Extensive experiments have been carried out on many multi- spectral images for use in prostate cancer diagnosis and quantitative results showed the efficiency of this method compared to the [standard] Gray Level Difference Method," the team concludes. "The results indicate a significant improvement in terms of global accuracy rate."


Story Source:

The above story is based on materials provided by Inderscience. Note: Materials may be edited for content and length.


Journal Reference:

  1. Bourennane et al. Texture analysis of multispectral prostate tissue using generalized gray level difference method. nt. J. Signal and Imaging Systems Engineering, 2012; vol 1, issue 3/4, pp 1-8

Cite This Page:

Inderscience. "Shades of grey and prostate cancer." ScienceDaily. ScienceDaily, 23 July 2012. <www.sciencedaily.com/releases/2012/07/120723095053.htm>.
Inderscience. (2012, July 23). Shades of grey and prostate cancer. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/07/120723095053.htm
Inderscience. "Shades of grey and prostate cancer." ScienceDaily. www.sciencedaily.com/releases/2012/07/120723095053.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins